Hidradenitis

New data showed that Bimzelx sustained disease control of hidradenitis suppurativa up to 2 years, UCB announced in a press release.

As the year comes to a close, Healio Dermatology has assembled this year’s top hidradenitis suppurativa articles.

Hidradenitis suppurativa was linked to adverse maternal and offspring outcomes during the peripartum period and in the long-term, according to a study.

The FDA has approved Bimzelx for the treatment of moderate to severe hidradenitis suppurativa in adults, UCB announced in a press release.

Genetic variants found in hidradenitis suppurativa may be correlated to genetic variants in coronary artery disease and diabetes, according to a study.

Researchers have dosed the first patient in a phase 2 trial evaluating AVTX-009 for the treatment of hidradenitis suppurativa, Avalo Therapeutics announced in a press release.

Bimzelx maintained improvements in hidradenitis suppurativa for up to 2 years, according to an oral presentation on two phase 3 studies and one extension trial at the European Academy of Dermatology and Venerology Congress.

Semaglutide was shown to reduce hidradenitis suppurativa flares in patients with obesity, according to a study presented at the European Academy of Dermatology and Venereology meeting.

The Global Hidradenitis Suppurativa Atlas has produced a report offering the first global data on the diagnosis, impact and treatment of hidradenitis suppurativa, according to a press release.

CLEVELAND — Hidradenitis suppurativa research has hit roadblocks including high placebo responses and difficulty in accurate assessments, according to Amit Garg, MD, professor and chair of the department of dermatology at Northwell Health.